Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection.

Epstein-Barr virus (EBV), an oncogenic herpesvirus of humans, displays selective tropism for B lymphocytes and epithelial cells. EBV tropism is thought to be determined in part by a unique host cell receptor termed CR2 (CD21). Although previous studies have demonstrated that CR2 mediates EBV binding...

Description complète

Détails bibliographiques

Publié dans:	J Virol
Auteurs principaux:	Nemerow, G R, Mullen, J J, Dickson, P W, Cooper, N R
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 1990
Sujets:	Research Article
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC249254/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2154612/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.64.3.1348-1352.1990
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!